ヤマナカ ヒサシ
  山中 寿
   所属   医学部 医学科(東京女子医科大学病院)
   職種   客員教授
論文種別 原著
言語種別 英語
査読の有無 査読なし
表題 Sustainable Efficacy of Switching From Intravenous to Subcutaneous Tocilizumab Monotherapy in Patients With Rheumatoid Arthritis.
掲載誌名 正式名:Arthritis care & research
略  称:Arthritis Care Res (Hoboken)
ISSNコード:(2151-4658)2151-464X(Linking)
掲載区分国外
巻・号・頁 67(10),pp.1354-62
著者・共著者 Ogata Atsushi, Atsumi Tatsuya, Fukuda Takaaki, Hirabayashi Yasuhiko, Inaba Masaaki, Ishiguro Naoki, Kai Motokazu, Kawabata Daisuke, Kida Daihei, Kohsaka Hitoshi, Matsumura Ryutaro, Minota Seiji, Mukai Masaya, Sumida Takayuki, Takasugi Kiyoshi, Tamaki Shigenori, Takeuchi Tsutomu, Ueda Atsuhisa, Yamamoto Kazuhiko, Yamanaka Hisashi, Yoshifuji Hajime, Nomura Akira,
発行年月 2015/10
概要 Efficacy is adequately maintained in most patients switching from TCZ-IV (8 mg/kg/4 weeks) to TCZ-SC (162 mg/2 weeks) monotherapy. Patients receiving TCZ-IV can switch to TCZ-SC without serious safety concerns. Clinical efficacy may be reduced after switching in some patients with high body weight.
DOI 10.1002/acr.22598
PMID 25832859